Carter Charles Ross
- SEC CIK
- 0001779359
No open-market purchases or sales filed in the past year.
Current role at each company
- OVID Ovid Therapeutics Inc.Chief Financial Officeras of Jul 8, 2026
- CERO Cero Therapeutics Holdings, Inc.Chief Financial Officeras of Jul 1, 2024
- ICAD Icad IncCHIEF FINANCIAL OFFICERas of Jan 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Carter Charles Ross as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ICAD Icad Inc
CHIEF FINANCIAL OFFICER1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2021 (view filing) | Dec 8 | 7 daysLate | Carter Charles RossCHIEF FINANCIAL OFFICER | PPurchase | +7.00K | $7.05 | +$49.4K | New position7.00K after |